Nikola Gardić, MD, PhD, TA
Resident Physician
Phone021/4805317
Nikola Gardić graduated from the Faculty of Medicine at the University of Novi Sad in 2022. During his studies, he received multiple awards for his achievements. He completed his doctoral studies in biomedical sciences in 2026, defending his dissertation on the topic "Cytomorphological and histomorphological characteristics of lung adenocarcinoma with positive predictive biomarkers." He has been professionally engaged at the Institute of Pulmonary Diseases of Vojvodina in the Department of Pathological Anatomy and Molecular Diagnostics since 2023. He enrolled in a residency in pathology in 2024, which is currently ongoing. He also worked as a teaching assistant at the Faculty of Pharmacy in Novi Sad in the subjects of anatomy, histology, and pathophysiology.
He is the author of 13 scientific papers, seven of which have been published in international journals. He has actively participated in numerous international and domestic congresses with over 20 professional presentations. His work is primarily focused on thoracic pathology.
Since April 2025, he has been appointed as an assistant at the Department of Pathology, Faculty of Medicine, University of Novi Sad.
Professional expertise/field
Pathology
Teaching engagement
Faculty of Medicine, University of Novi Sad
Department of Pathology
| Field | Year of completion | Degree | Faculty | |
|---|---|---|---|---|
| Residency | Pathology | Ongoing | Faculty of Medicine Novi Sad | |
| Faculty | Medicine | 2022 | Doctor of Medicine | Faculty of Medicine Novi Sad |
| Doctorate | Pathology | 2026 | Doctor of Medical Sciences | Faculty of Medicine Novi Sad |
| Training name | Field | Year | Organizer |
|---|---|---|---|
| 1. | Pathology | 2024 | 8th Annual Course of Academy of Immunohistochemistry |
| 2. | Pathology | 2025 | European School of Pathology (EScoP) course for Thyroid Pathology |
| 3. | Pathology | 2025 | The 17th Bryan Warren School of Pathology |
| Period | Title | Project role |
|---|---|---|
| 2025-Ongoing | Detection of EGFR mutations in non-small cell lung cancer by digital droplet PCR | participant |
| 2026-Ongoing | Morphological and Predictive Properties of Microglia in Glioma and Neuroglial Tumors | participant |
ESP – European Society of Pathology
UPCS – Association of Pathologists and Cytologists of Serbia
DLV-SLD – Medical Society of Vojvodina – Serbian Medical Society
Gardić N, Lovrenski A, Sekeruš V, Kašiković Lečić S, Bijelović M, Lakić T, Ilić A, Zarić B, Glumac S. Cytomorphological and histomorphological features of lung adenocarcinoma with epidermal growth factor receptor mutation and anaplastic lymphoma kinase gene rearrangement. Oncol Lett. 2024 Nov 4;29(1):40.
Bijelović M, Gardić N, Lovrenski A, Petrović D, Kozoderović G, Lalošević V, Vračar V, Lalošević D. Cladosporium species novum Invasive Pulmonary Infection in a Patient with Post-COVID-19 Syndrome and AIDS. Diagnostics (Basel). 2025 Mar 20;15(6):781.
Gardić N, Tomić S, Miljković D, Lovrenski A. A Case Series: Can a Cytological Smear Indicate the Histological Type of Thymoma and Distinguish Thymoma From Thymic Carcinoma? Diagn Cytopathol. 2025 Sep;53(9):E165-E169.
Gardić N, Moiljković D, Lovrenski A. Cytomorphological features as subtyping tool of non-small cell lung cancer in brushing bronchoscopic samples. J Cytol. 2024;41(3):143-9.
Gardić N, Miljković D, Stojšić V, Lovrenski A. A brief overview of imprint cytology in thoracic cytopathology. Cytojournal. 2025 Oct 23;22:85.
Lovrenski A, Gardić N, Šunjević M, Dragišić D, Vučković D. Alveolar Adenoma: A 20-Year Experience at a Western Balkan University Hospital and a Literature Review. Int J Surg Pathol. 2024 Aug;32(5):982-991.
Lovrenski A, Gardić N, Tegeltija D, Miljković D. Diagnostic accuracy and adequacy of peripheral pulmonary nodules samples obtained by transthoracic needle aspiration. Cytopathology. 2023;34(1):35-42.
Gardić N, Lovrenski A, Koledin B, Miljković D, Baljak J, Vučković D. Ultra-rare primary pulmonary sarcoma – Case report. MD-Medical Data. 2023;15(3):119-22.
Gardić N, Zelenović T, Tegeltija D, Krajinović B, Milenković A, Lovrenski A. Angioinvasive pulmonary aspergillosis as a complication of treatment protocol for acute B lymphoblastic leukemia. MD-Medical Data. 2021;13(3-4):143-146.
Poparić M, Sečen N, Matijašević J, Baljak J, Gardić N. Pericardial effusion in patients with lung cancer – seven-year experience. MD-Medical Data. 2024;16(1):31-5.
| Year | Title | Location | Role | Lecture/session title |
|---|---|---|---|---|
| 2024 | European Congress of Pathology | Florence, Italy | Active Participant | Is the expression of programmed cell death 1 related to histological features in small biopsies of lung adenocarcinoma? |
| 2024 | European Congress of Pathology | Florence, Italy | Active Participant | Pathological characteristics as predictors of multifocality in papillary thyroid carcinoma |
| 2023 | 7th Congress of Respiratory Medicine of Serbia with International Participation | Vrnjačka Banja, Serbia | Active Participant | Giant ganglioneuroma of the thorax – case report. |
| 2023 | 7th Congress of Respiratory Medicine of Serbia with International Participation | Vrnjačka Banja, Serbia | Active Participant | Comparison of clinical and pathological characteristics of patients with complete regression and without signs of regression of non-small cell lung cancer after neoadjuvant chemotherapy |
| 2024 | Congress of Pathologists and Cytologists of Serbia | Novi Sad, Serbia | Active Participant | Lung cryptococcosis as a sign of an underlying immunocompromised condition – case report. |
| 2024 | Congress of Pathologists and Cytologists of Serbia | Novi Sad, Serbia | Active Participant | Cytological and histological features of lung adenocarcinoma with positive predictive biomarkers |
| 2024 | Congress of Pathologists and Cytologists of Serbia | Novi Sad, Serbia | Active Participant | Epithelioid hemangioendothelioma of the lung – case report |
| 2024 | Congress of Pathologists and Cytologists of Serbia | Novi Sad, Serbia | Active Participant | Mediastinal mixed germ cell tumor with a rare component – case report |